• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS COAGUCHEK XS SYSTEM; PROTHROMBIN TIME TEST STRIPS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS COAGUCHEK XS SYSTEM; PROTHROMBIN TIME TEST STRIPS Back to Search Results
Catalog Number 04625374160
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problems Gastrointestinal Hemorrhage (4476); Melena (4480)
Event Date 06/17/2021
Event Type  Injury  
Manufacturer Narrative
The meter and strips have been requested for return.The product has not been received at this time.If the product is returned in the future, a follow-up report will be submitted.Routine retention testing was performed.Test strip retention samples passed the internal inspection.Per product labeling, "coaguchek uses human recombinant thromboplastin.Therefore, the comparability to other human recombinant thromboplastins is best, whereas higher deviations can occur with other thromboplastins.However, those higher differences between thromboplastins of different (rabbit, bovine based) origin are not a coaguchek specific issue.Similar differences can be observed when a human recombinant thromboplastin-based laboratory method is compared against several other (rabbit, bovine-based) laboratory methods." the medical assessment stated the identified dieulafoy lesion is a large tortuous arteriole most commonly in the submucosal stomach wall, which erodes and bleeds.The presence of anticoagulation makes the risk for bleedings higher.An ulcus dieulafoy is not caused by anticoagulation, but is an independent medical condition.The patient's wife was aware of tarry stools 2 days prior to reporting it to the doctor on (b)(6) 2021.The patient's wife did not mention the tarry stools to the doctor at the time of the 2.3 inr on (b)(6) 2021 and the patient's warfarin dosage was increased by the doctor's advice based on this result which was slightly below therapeutic range of 2.5 - 3.5 inr.Different inr results on different days are generally not comparable.Initial reporter occupation was lay user/patient.
 
Event Description
There was an allegation the patient was hospitalized for bleeding of the stomach lining while using coaguchek xs meter serial number (b)(4).On (b)(6) 2021 at an unknown time, the result was 2.3 inr.Based on the meter result and the doctor's advice, 1.5 mg of warfarin was added to the normal 3 mg dose for that day.The patient's wife had noticed a darkening of the stool two days before reporting it to the doctor on (b)(6) 2021.The patient had not mentioned the darker stools to the doctor on the (b)(6) 2021 prior to the warfarin adjustment.On (b)(6) 2021, the patient also had symptoms of weakness and issues standing.The patient was taken to the hospital er and then sent to another hospital where blood work was performed.The warfarin was stopped for three days based on a laboratory result of 4.8 inr.The laboratory reagent was not known.On (b)(6) 2021, an endoscopy determined the bleeding was caused by a rare condition called dieulafoy lesions (defined as a vascular abnormality, most commonly in the stomach wall, that erodes and bleeds).During the endoscopy, the bleeding section of the stomach lining was cauterized and clipped.The patient received one unit of blood in the er and two units of blood later in the hospital.The patient's inr results were reported to be "still high" on release from the hospital.The patient's inr result was estimated to be above 4.0 inr but less than 4.8 inr.The patient was advised to withhold warfarin from (b)(6) 2021.The patient began taking 1 mg warfarin on (b)(6) 2021.The therapeutic range was 2.5-3.0 inr and the patient tests weekly.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COAGUCHEK XS SYSTEM
Type of Device
PROTHROMBIN TIME TEST STRIPS
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
michael leslie
9115 hague road
na
indianapolis, IN 46250
3175214343
MDR Report Key12204138
MDR Text Key268263978
Report Number1823260-2021-02122
Device Sequence Number1
Product Code GJS
UDI-Device Identifier00365702127104
UDI-Public00365702127104
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K062925
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer
Reporter Occupation Other
Type of Report Initial
Report Date 07/21/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date05/31/2022
Device Catalogue Number04625374160
Device Lot Number50772321
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 06/22/2021
Initial Date FDA Received07/21/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age80 YR
Patient Weight77
-
-